Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.
Mar 4, 2022
0
62
A team of researchers at the New York-Presbyterian/Weill Cornell Medical Center announced that a woman they have been treating for both HIV and leukemia has apparently been cured of HIV—14 months after discontinuing antivirals, ...
An international research group at the RIKEN Cluster for Pioneering Research (CPR) has successfully treated cancer in mice using metal catalysts that assemble anticancer drugs together inside the body. Published in the scientific ...
Jan 10, 2022
0
82
An immunotherapy harnessing the immune system's "natural killer" cells has proven effective in treating acute myeloid leukemia (AML) in some adults whose cancers return. Now, researchers at Washington University School of ...
Dec 14, 2021
0
36
Six different COVID-19 boosters are safe and provoke strong immune responses in people who have previously received a two-dose course of ChAdOx1-nCov19 (Oxford–AstraZeneca [ChAd]) or BNT162b2 (Pfizer-BioNTech [BNT]), according ...
Dec 3, 2021
0
350
Pancreatic cancer is extremely difficult to treat. By the time it is detected, the cancer often has reached an advanced stage, and patients usually do not survive longer than one year after diagnosis. An aggressive chemotherapy ...
Dec 1, 2021
0
42
A new treatment may be on the horizon for people with a major form of inflammatory bowel disease (IBD) called Crohn's disease, after a McMaster University-led study identified serotonin as a possible trigger of flare-ups. ...
Nov 9, 2021
0
134
An investigation into the origins of the sensation of pain has led to the development of a novel and durable treatment for inflammatory pain that could be a promising alternative to opioids. The preclinical research was conducted ...
Oct 4, 2021
1
139
Researchers at UC San Francisco and UC San Diego have mapped out how hundreds of mutations involved in two types of cancer affect the activity of proteins that are the ultimate actors behind the disease. The work points the ...
Sep 30, 2021
0
67
Most side effects after a third dose of a COVID vaccine are mild or moderate, and occur at about as often as after shot two, a US study showed Tuesday in a finding that was expected but nonetheless reassuring.
Sep 28, 2021
1
265
